San Diego, California--(Newsfile Corp. - October 10, 2024) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of SageTherapeutics, Inc. (NASDAQ: SAGE) securities between ...
SageTherapeutics (NASDAQ:SAGE – Get Free Report)‘s stock had its “market perform” rating restated by analysts at Raymond James in a note issued to investors on Thursday, MarketBeat.com reports.
On Wednesday, SAGE Therapeutics Inc (SAGE) stock saw a modest uptick, ending the day at $6.49 which represents a slight increase of $0.06 or 0.93% from the prior close of $6.43. The stock opened at $6 ...
Shares of Werewolf Therapeutics (NASDAQ:HOWL) added ~34% after announcing two partial remissions in an early-stage clinical program for WTX-124, one of its lead cancer candidates targeted at solid ...
Some results have been hidden because they may be inaccessible to you